Global Allergen Immunotherapy Market Size, Share, Trends, Industry Growth by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Others), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Hymenoptera Venom Allergy, Others), by End-User, by Distribution Channel, by End-User, and Forecast to 2030

Report ID: RC157701 | Report Format: PDF + Excel | Starting Price: 2520/- USD | Last Updated: July 9th, 2023

The global allergen immunotherapy market size was valued at over USD 1.5 billion in 2022 and anticipated to register a significant CAGR of over 9% during the forecast period. The market is driven by factors such as the increasing prevalence of allergies, growing awareness and diagnosis of allergies, favorable guidelines and recommendations, advancements in allergen extracts, technological advancements in administration, patient preference for long-term allergy management, increasing healthcare expenditure, and ongoing research and development initiatives. These factors contribute to the market’s growth by addressing the rising demand for effective allergy treatments, improving safety and efficacy, enhancing accessibility and convenience, and providing long-term solutions for allergy management.

The latest statistics from the World Health Organization (WHO) indicate that 57% of adult patients with allergic rhinitis experience sleep disturbances, fatigue, and decreased cognitive function. This highlights the significant impact of allergies on daily life and underscores the need for effective treatments. The presence of a promising product pipeline for allergic reaction treatments is expected to drive further growth in the market, offering hope for improved management and relief for those affected by allergies.

Market Snapshot:

Benchmark Year 2022
Market Size > USD 1.5 Billion in 2022
Market Growth (CAGR) > 9% (2023-2030)
Largest Market Share Europe
Analysis Period 2020-2030
Market Players ALK-Abelló A/S, Stallergenes Greer, Allergy Therapeutics, Anergis SA, HAL Allergy Group, and Biomay AG

Market Drivers:

Rising Prevalence of Allergies: There has been a significant increase in the prevalence of allergic diseases, such as allergic rhinitis, asthma, and food allergies, globally. This rising incidence of allergies is driving the demand for effective treatment options like allergen immunotherapy.

Growing Awareness and Diagnosis: There is a growing awareness among individuals and healthcare professionals about the benefits of allergen immunotherapy in treating allergies. Improved diagnostic techniques and increased access to allergy testing have led to better identification and diagnosis of allergies, resulting in higher demand for allergen immunotherapy.

Favorable Guidelines and Recommendations: Allergen immunotherapy is supported by guidelines and recommendations from various medical organizations, including the World Allergy Organization (WAO) and the European Academy of Allergy and Clinical Immunology (EAACI). These guidelines promote the use of allergen immunotherapy as an effective treatment option, thereby driving its adoption.

Advancements in Allergen Extracts: The development of standardized and high-quality allergen extracts has improved the safety and efficacy of allergen immunotherapy. The use of modified allergen extracts, such as recombinant allergens or hypoallergenic derivatives, is also being explored, providing new opportunities for the market.

Technological Advancements: Technological advancements have enhanced the administration of allergen immunotherapy, making it more convenient and patient-friendly. For example, sublingual immunotherapy (SLIT) has gained popularity due to its non-invasive nature and ease of administration.

Patient Preference for Long-term Allergy Management: Allergen immunotherapy offers a long-term solution for allergy management by targeting the underlying cause of allergies. Many patients prefer allergen immunotherapy over symptomatic relief medications, as it can provide lasting benefits and potentially reduce the need for ongoing medication use.

Increasing Healthcare Expenditure: The overall growth in healthcare expenditure, particularly in developed economies, contributes to the expansion of the allergen immunotherapy market. Increased investment in healthcare infrastructure and services allows for greater accessibility and affordability of allergen immunotherapy.

Research and Development Initiatives: Ongoing research and development activities aimed at improving the safety and efficacy of allergen immunotherapy are driving market growth. This includes the development of novel allergens, combination therapies, and personalized approaches, which hold promising potential for the future.

Market Insights:

Market Analysis by Treatment:

The global allergen immunotherapy market is bifurcated into treatment, allergy type, end-user, distribution channel, and geography. on the basis of treatment, the subcutaneous immunotherapy (SCIT) segment dominated the global market in 2022 and expected to grow at a significant CAGR over the forecast period. SCIT has been widely used for many years and is considered the gold standard for allergen immunotherapy. It has a well-established efficacy and safety profile and is supported by extensive clinical research and guidelines. SCIT involves the administration of allergen extracts through subcutaneous injections, typically administered in healthcare settings under medical supervision. This method allows for precise control over the dosage and gradual increase in allergen exposure, leading to desensitization and long-term reduction in allergy symptoms.

Segment Definition:

Subcutaneous Immunotherapy (SCIT): SCIT involves the administration of allergen extracts through subcutaneous injections. It has been widely used and studied for decades and is considered the gold standard for allergen immunotherapy. SCIT delivers gradually increasing doses of allergens to desensitize the immune system and reduce allergic reactions over time. It is typically administered in a healthcare setting under medical supervision.

Sublingual Immunotherapy (SLIT): SLIT involves the administration of allergen extracts as sublingual tablets, drops, or sprays. It is a convenient and non-invasive alternative to SCIT. Patients self-administer SLIT at home by placing the allergen extract under the tongue and holding it for a specific duration. SLIT also aims to desensitize the immune system and reduce allergy symptoms. It has gained popularity due to its ease of use and reduced risk of severe allergic reactions compared to SCIT.

Others: This category includes alternative or emerging forms of allergen immunotherapy that are still under development or being researched. These may include novel administration methods, such as oral immunotherapy or epicutaneous immunotherapy, as well as new formulations or delivery systems for allergen extracts.

Market Analysis by Allergy Type:

On the basis of allergy type, the global allergen immunotherapy market is segmented into allergic rhinitis, allergic asthma, hymenoptera venom allergy, and other allergic conditions. Allergic rhinitis and allergic asthma are the most prevalent and well-established segments, given the high prevalence of these conditions globally. Hymenoptera venom allergy represents a specialized segment for individuals at risk of severe insect sting allergies. The “other allergic conditions” category recognizes the potential for expanding the use of allergen immunotherapy beyond the currently established applications.

Segment Definition:

Allergic Rhinitis: Allergic rhinitis, also known as hay fever, is one of the most common allergy types. It is characterized by inflammation and irritation of the nasal passages, resulting in symptoms such as sneezing, itching, nasal congestion, and runny nose. Allergen immunotherapy can help reduce the severity of allergic rhinitis symptoms and provide long-term relief.

Allergic Asthma: Allergic asthma is a chronic respiratory condition characterized by airway inflammation and bronchial hyperresponsiveness triggered by allergens. Allergen immunotherapy can help alleviate asthma symptoms and reduce the frequency and severity of asthma attacks in individuals with allergic triggers.

Hymenoptera Venom Allergy: Hymenoptera venom allergy refers to allergies caused by stings from insects such as bees, wasps, hornets, or ants. Allergen immunotherapy can be used to desensitize individuals with a history of severe allergic reactions to hymenoptera venom. It helps reduce the risk of severe reactions upon subsequent stings.

Other Allergic Conditions: This category includes other allergic conditions, such as atopic dermatitis (eczema), food allergies, or less common allergies. Allergen immunotherapy for these conditions is still under investigation and development, with ongoing research to explore its effectiveness in managing these specific allergies.

The allergen immunotherapy market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

  • 2020-21 – Historical Year
  • 2022 – Base Year
  • 2023-2030 – Forecast Period

Market Segmentation:

By Treatment:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
  • Others

By Allergy Type:

  • Allergic Rhinitis
  • Allergic Asthma
  • Hymenoptera Venom Allergy
  • Other Allergic Conditions

By End-User:

  • Adults
  • Pediatric Patients

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regional Analysis:

On the basis of region, Europe is the leading region in the geography segment of the allergy immunotherapy market. The region’s growth is primarily driven by the increasing prevalence of seasonal rhinitis. Recent research from the European Academy of Allergy and Clinical Immunology (EAACI) indicates that approximately 20% of the European population suffers from seasonal allergies, with concerns about severe allergic reactions, asthma attacks, or even fatalities. Additionally, the availability of affordable reimbursement scenarios for allergic immunotherapy contributes to market growth in the region. North America follows as the second-largest regional segment, benefiting from a supportive regulatory environment provided by the USFDA, which fosters the expansion of allergen immunotherapy. The Asia Pacific region is expected to experience the fastest market growth. The region’s growing industrialization has led to an increase in allergic reactions caused by house dust mites, air pollution, pollen grains, and other factors. Rising public health awareness about the benefits of allergic immunotherapy further fuels market growth in the region.

Competitive Assessment

Some of the prominent market players operating in the global allergen immunotherapy market are ALK-Abelló A/S, Stallergenes Greer, Allergy Therapeutics, Anergis SA, HAL Allergy Group, and Biomay AG. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

  • ALK-Abelló A/S
  • Stallergenes Greer
  • Allergy Therapeutics
  • Anergis SA
  • HAL Allergy Group
  • Biomay AG
  • DBV Technologies
  • Circassia Pharmaceuticals
  • Merck KGaA (Allergopharma)
  • ASIT biotech
  • Leti Pharma
  • HolisterStier Allergy

Key Questions Answered by Allergen Immunotherapy Market Report

  • Global allergen immunotherapy market forecasts from 2023-2030
  • Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
  • Allergen immunotherapy submarket forecasts from 2023-2030 covering the market by treatment, allergy type, end-user, distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level allergen immunotherapy markets from 2023-2030
  • Competitive Landscape and market positioning of top 10 players operating in the market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Allergen Immunotherapy Market Portraiture
2.2. Global Allergen Immunotherapy Market, by Treatment, 2022 (USD Mn)
2.3. Global Allergen Immunotherapy Market, by Allergy Type, 2022 (USD Mn)
2.4. Global Allergen Immunotherapy Market, by End-User, 2022 (USD Mn)
2.5. Global Allergen Immunotherapy Market, by Distribution Channel, 2022 (USD Mn)
2.6. Global Allergen Immunotherapy Market, by Geography, 2022 (USD Mn)

 

3. Global Allergen Immunotherapy Market Analysis


3.1. Allergen Immunotherapy Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. PESTLE Analysis
3.8. COVID-19 Impact Analysis

 

4. Global Allergen Immunotherapy Market By Treatment, 2020 – 2030 (USD Mn)


4.1. Overview
4.2. Subcutaneous Immunotherapy (SCIT)
4.3. Sublingual Immunotherapy (SLIT)
4.4. Others

 

5. Global Allergen Immunotherapy Market By Allergy Type, 2020 – 2030 (USD Mn)


5.1. Overview
5.2. Allergic Rhinitis
5.3. Allergic Asthma
5.4. Hymenoptera Venom Allergy
5.5. Other Allergic Conditions

 

6. Global Allergen Immunotherapy Market By End-User, 2020 – 2030 (USD Mn)


6.1. Overview
6.2. Adults
6.3. Pediatric Patients

 

7. Global Allergen Immunotherapy Market By Distribution Channel, 2020 – 2030 (USD Mn)


7.1. Overview
7.2. Hospital Pharmacy
7.3. Retail Pharmacy
7.4. Others

 

8. North America Allergen Immunotherapy Market Analysis and Forecast, 2020 – 2030 (USD Mn)


8.1. Overview
8.2. North America Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
8.3. North America Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
8.4. North America Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
8.5. North America Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
8.6. North America Allergen Immunotherapy Market by Country, (2020-2030 USD Mn)
8.6.1. U.S.
8.6.1.1. U.S. Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
8.6.1.2. U.S. Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
8.6.1.3. U.S. Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
8.6.1.4. U.S. Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
8.6.2. Canada
8.6.2.1. Canada Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
8.6.2.2. Canada Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
8.6.2.3. Canada Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
8.6.2.4. Canada Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)

 

9. Europe Allergen Immunotherapy Market Analysis and Forecast, 2020 - 2030 (USD Mn)


9.1. Overview
9.2. Europe Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.3. Europe Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.4. Europe Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.5. Europe Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6. Europe Allergen Immunotherapy Market by Country, (2020-2030 USD Mn)
9.6.1. Germany
9.6.1.1. Germany Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.1.2. Germany Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.1.3. Germany Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.1.4. Germany Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6.2. U.K.
9.6.2.1. U.K. Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.2.2. U.K. Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.2.3. U.K. Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.2.4. U.K. Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6.3. France
9.6.3.1. France Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.3.2. France Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.3.3. France Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.3.4. France Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6.4. Spain
9.6.4.1. Spain Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.4.2. Spain Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.4.3. Spain Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.4.4. Spain Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6.5. Italy
9.6.5.1. Italy Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.5.2. Italy Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.5.3. Italy Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.5.4. Italy Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
9.6.6.2. Rest of Europe Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
9.6.6.3. Rest of Europe Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
9.6.6.4. Rest of Europe Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)

 

10. Asia Pacific Allergen Immunotherapy Market Analysis and Forecast, 2020 - 2030 (USD Mn)


10.1. Overview
10.2. Asia Pacific Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.3. Asia Pacific Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.4. Asia Pacific Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.5. Asia Pacific Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
10.6. Asia Pacific Allergen Immunotherapy Market by Country, (2020-2030 USD Mn)
10.6.1. China
10.6.1.1. China Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.6.1.2. China Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.6.1.3. China Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.6.1.4. China Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
10.6.2. Japan
10.6.2.1. Japan Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.6.2.2. Japan Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.6.2.3. Japan Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.6.2.4. Japan Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
10.6.3. India
10.6.3.1. India Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.6.3.2. India Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.6.3.3. India Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.6.3.4. India Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
10.6.4. South Korea
10.6.4.1. South Korea Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.6.4.2. South Korea Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.6.4.3. South Korea Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.6.4.4. South Korea Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
10.6.5. Rest of Asia Pacific
10.6.5.1. Rest of Asia Pacific Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
10.6.5.2. Rest of Asia Pacific Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
10.6.5.3. Rest of Asia Pacific Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
10.6.5.4. Rest of Asia Pacific Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)

 

11. Latin America (LATAM) Allergen Immunotherapy Market Analysis and Forecast, 2020 - 2030 (USD Mn)


11.1. Overview
11.2. Latin America Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
11.3. Latin America Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
11.4. Latin America Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
11.5. Latin America Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
11.6. Latin America Allergen Immunotherapy Market by Country, (2020-2030 USD Mn)
11.6.1. Brazil
11.6.1.1. Brazil Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
11.6.1.2. Brazil Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
11.6.1.3. Brazil Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
11.6.1.4. Brazil Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
11.6.2. Mexico
11.6.2.1. Mexico Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
11.6.2.2. Mexico Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
11.6.2.3. Mexico Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
11.6.2.4. Mexico Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
11.6.3.2. Rest of Latin America Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
11.6.3.3. Rest of Latin America Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
11.6.3.4. Rest of Latin America Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)

 

12. Middle East and Africa Allergen Immunotherapy Market Analysis and Forecast, 2020 - 2030 (USD Mn)


12.1. Overview
12.2. MEA Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
12.3. MEA Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
12.4. MEA Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
12.5. MEA Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
12.6. Middle East and Africa Allergen Immunotherapy Market, by Country, (2020-2030 USD Mn)
12.6.1. GCC
12.6.1.1. GCC Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
12.6.1.2. GCC Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
12.6.1.3. GCC Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
12.6.1.4. GCC Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
12.6.2. South Africa
12.6.2.1. South Africa Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
12.6.2.2. South Africa Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
12.6.2.3. South Africa Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
12.6.2.4. South Africa Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Allergen Immunotherapy Market by Treatment, (2020-2030 USD Mn)
12.6.3.2. Rest of MEA Allergen Immunotherapy Market by Allergy Type, (2020-2030 USD Mn)
12.6.3.3. Rest of MEA Allergen Immunotherapy Market by End-User, (2020-2030 USD Mn)
12.6.3.4. Rest of MEA Allergen Immunotherapy Market by Distribution Channel, (2020-2030 USD Mn)

 

13. Company Profiles


13.1. ALK-Abelló A/S
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Stallergenes Greer
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. Allergy Therapeutics
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Anergis SA
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. HAL Allergy Group
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Biomay AG
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. DBV Technologies
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Circassia Pharmaceuticals
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Merck KGaA (Allergopharma)
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. ASIT biotech
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis
13.11. Leti Pharma
13.11.1. Business Description
13.11.2. Financial Health and Budget Allocation
13.11.3. Product Positions/Portfolio
13.11.4. Recent Development
13.11.5. SWOT Analysis
13.12. HolisterStier Allergy
13.12.1. Business Description
13.12.2. Financial Health and Budget Allocation
13.12.3. Product Positions/Portfolio
13.12.4. Recent Development
13.12.5. SWOT Analysis
Fill the given form to inquiry before buying for Global Allergen Immunotherapy Market Size, Share, Trends, Industry Growth by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Others), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Hymenoptera Venom Allergy, Others), by End-User, by Distribution Channel, by End-User, and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying
Schedule a Call


Select License Type
$ 3600/- Single User License
$2520 (Limited Time Offer)
$ 5200/- Multi User License
$ 6995/- Corporate License

Paypal Certified Payment
For Any Assitance

Email: sales@researchcorridor.com
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price

Impacts of COVID-19
COVID-19 Impact on the Global Allergen Immunotherapy Market Size, Share, Trends, Industry Growth by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Others), by Allergy Type (Allergic Rhinitis, Allergic Asthma, Hymenoptera Venom Allergy, Others), by End-User, by Distribution Channel, by End-User, and Forecast to 2030 Market

Get in Touch

For any coustomized project, contact us here:


Our Clients